...
首页> 外文期刊>Journal of radiology case reports >Disseminated Peritoneal Leiomyomatosis Status Post Laparoscopic Hysterectomy with Morcellation
【24h】

Disseminated Peritoneal Leiomyomatosis Status Post Laparoscopic Hysterectomy with Morcellation

机译:腹腔镜子宫全切术切除后的弥漫性腹膜平滑肌瘤状态

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Uterine leiomyomas (fibroids) are common benign neoplasms, which develop from the muscular tissue of the uterus with an estimated incidence of 20–40% in women of reproductive age. In the early nineties, power morcellators were introduced and became commonly used during hysterectomy for symptomatic fibroids. However, if all fragments are not removed, they may parasitize to other blood supply and present as abdominal or pelvic masses. Unfortunate cases have also been reported in which uterine sarcomas seeded throughout the abdomen and pelvis secondary to morcellation. The Food and Drug Administration (FDA) estimates that 1 in 350 women undergoing hysterectomy or myomectomy for fibroids is found to have an unsuspected uterine sarcoma. As a result, the FDA issued a press release in 2014 discouraging the use of power morcellators. Recently, the FDA approved a new containment device, the PneumoLiner, for use with certain power morcellation devices. However, it is unknown if this device will help to reduce the risk of seeding fibroids and unsuspected uterine malignancies. We present a case in which a patient who underwent morcellation therapy for symptomatic fibroids presented with recurrent abdominal and pelvic leiomyomas mimicking malignancy. Keywords: Fibroids, morcellator, seeding, implants, pelvis, uterus, recurrent fibroids, morcellation, Computed Tomography, Ultrasound, leiomyomaCASE REPORTA 50-year-old female with a past medical history of uterine fibroids status post robotic hysterectomy with morcellation presented with acute abdominal pain. She had a noteworthy family history of uterine leiomyosarcoma and lymphoma.The patient was initially diagnosed with multiple uterine fibroids via ultrasound in December 2010 [Figure 1], the largest of which was posteriorly located and measured 6.7 × 5.8 × 4.9 cm. Conservative management and routine follow up was planned. The patient returned for follow up ultrasound in June 2011 [Figure 2], which demonstrated interval enlargement of the fibroids now measuring up to 8.3 cm in greatest dimension. A robotic approach was not being offered at that time at this institution. Therefore, she sought evaluation at an outside institution where she ultimately underwent a robotic hysterectomy with a power morcellator. Open in a separate windowFigure 1 50 year old female patient: Diagnosis of Disseminated Peritoneal Leiomyomatosis Status Post Laparoscopic Hysterectomy with Morcellation.Findings: Transabdominal ultrasound of the uterus in the sagittal plane at original presentation for pelvic pain, demonstrates a posteriorly located fibroid [cursors] measuring up to 6.7 cm.Technique: B-mode Transabdominal sonogram of the pelvis. Sagittal section of the uterus. Ultrasonography was performed using 3–5MHz curvilinear transducer.
机译:子宫平滑肌瘤(肌瘤)是常见的良性肿瘤,从子宫的肌肉组织发育而来,估计在育龄妇女中发病率为20-40%。九十年代初,功率粉碎器被引入,并在子宫切除术中用于有症状的肌瘤。但是,如果未清除所有碎片,它们可能会寄生于其他血液供应,并以腹部或骨盆肿块的形式出现。也有不幸的病例报道了子宫肉瘤在粉碎后继发于整个腹部和骨盆。美国食品药品监督管理局(FDA)估计,在接受子宫肌瘤切除术或子宫肌瘤切除术的350名妇女中,有1名患有未怀疑的子宫肉瘤。结果,FDA在2014年发布了新闻稿,劝阻动力粉碎机的使用。最近,FDA批准了一种新的密闭装置PneumoLiner,用于某些动力粉碎装置。但是,尚不清楚该装置是否有助于降低肌瘤和子宫恶性肿瘤播种的风险。我们提出的一个案例是,对有症状的肌瘤进行粉碎治疗的患者出现了模仿恶性肿瘤的复发性腹部和盆腔平滑肌瘤。关键字:肌瘤,粉碎器,种子,植入物,骨盆,子宫,复发性肌瘤,粉碎,计算机断层扫描,超声,平滑肌瘤病例报告一名50岁女性,过去有子宫肌瘤的病史,机器人子宫切除术后并伴有急性腹部的粉碎术疼痛。她有明显的子宫平滑肌肉瘤和淋巴瘤家族病史。该患者于2010年12月通过超声诊断出患有多发性子宫肌瘤[图1],其中最大的子宫肌瘤位于后方,尺寸为6.7×5.8×4.9 cm。保守的管理和例行的后续计划。该患者于2011年6月返回进行随访超声检查(图2),显示最大直径达8.3 cm的肌瘤间隔扩大。该机构当时未提供机器人方法。因此,她在一个外部机构寻求评估,在那里她最终通过动力粉碎机进行了子宫子宫切除术。在一个单独的窗口中打开图1 50岁的女性患者:腹腔镜子宫切除术并伴有粉碎术后的腹膜弥漫性子宫肌瘤的诊断结果。最长可达6.7厘米。技术:骨盆的B型经腹超声检查。子宫矢状切面。超声检查使用3–5MHz曲线换能器进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号